Second Circuit Sides with Government, Tosses Whistleblower Action Against Drug Manufacturers, PBMs
- December 04, 2020
The federal government has a legitimate interest in preserving scarce resources and its dismissal of a False Claims Act (FCA) whistleblower action was rationally related to that interest, the Second Circuit held December 1.
ARTICLE TAGS
You must be logged in to access this content.